Mitsui Chemicals, Inc. · TSE:4183

Mitsui Chemicals — Q3 FY2024 Earnings Presentation

35 slides from Mitsui Chemicals's earnings presentation, Feb 4, 2025

  1. Slide 1: Financial Summary: Results for 3rd Quarter of FY2024 & Outlook for FY2024

    Financial Summary Results for 3 rd Quarter of FY2024 & Outlook for FY2024 Mitsui Chemicals, Inc. ＜Remarks＞ February 4, 2025 FY2024 indicates the period from April 1, 2024 to March 31, 2025. This summary contains forward-looking statements about the future plans, strategies, belief and performance of

  2. Slide 2: Executive Summary: 3Q FY2024 Financial Results

    Executive Summary: 3Q FY2024 Financial Results ➢ Operating income before special items for the entire Group increased by 3.4 billion yen (＋5%) YoY. ➢ In the specialty chemicals domains, operating income before special items was up by 5.4 billion yen (+7%), as sales volumes were generally firm and te

  3. Slide 3: Executive Summary: FY2024 Financial Outlook

    Executive Summary: FY2024 Financial Outlook ➢ Operating income before special items for the entire Group is expected to be 105.0 billion yen for the full year, or an increase of 8.8 billion yen (+9%) YoY, which remains unchanged from the previous forecast, despite changes in the business environment

  4. Slide 4: Contents

    Contents 1. Results for 3rd Quarter of FY2024 (April 1, 2024 – December 31, 2024) 1) Trends of Key Market Indicators ･･･ 1 2) Major Investment Projects, etc. ･･･ 2 3) Consolidated Financial Highlights ･･･ 3-4 4) Sales Revenue and Operating Income before Special Items by Business Segment ･･･ 5 (compa

  5. Slide 5: 1. Results for 3rd Quarter of FY2024

    1. Results for 3 rd Quarter of FY2024 (April 1, 2024 –December 31, 2024) ・In accordance with the organizational reform implemented on April 1, 2024, we have revised the segments to which Honshu Chemical Industry Co., Ltd. and certain other consolidated subsidiaries and equity method affiliates in IC

  6. Slide 6: 1) Trends of Key Market Indicators

    1) Trends of Key Market Indicators FY2024 FY2024.2H Outlook 3Q⇒ (changes from previous 3Q 4Q 4Q outlook on Nov 7,2024) Ophthalmic lens materials market Firm demand Firm demand to continue Unchanged Life ＆ Healthcare Firm demand to continue; Solutions Firm demand; inventory level adjustments Agrochem

  7. Slide 7: 2) Major Investment Projects, etc.

    2) Major Investment Projects, etc. Major Investment projects Date Capacity FY22 FY23 FY24 FY25~ Acquisition of ophthalmic lens processing equipment maker November.'22 - Life & Establishment of JV for nonwovens businesses @Japan October.'23 - Healthcare Capacity expansion of MR™ High Refractive Index

  8. Slide 8: 3-1) Consolidated Financial Highlights

    3-1) Consolidated Financial Highlights (Billions of Yen) () Denotes a minus FY2023 FY2024 Increase Items % 1-3Q 1-3Q (Decrease) Sales revenue 1,274.5 1,338.8 64.3 5% Operating income before special items 72.4 75.8 3.4 5% (inc. Equity in earnings) 10.1 8.8 (1.3) (13%) Non-recurring items (12.4) (8.9)

  9. Slide 9: 3-2) Consolidated Financial Highlights (Operating Income before Special Items)

    3-2) Consolidated Financial Highlights (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials increased due to elimination of negative impact from inventory level adjustments in some markets in FY23. ［+］ Volume ・Elastomers increased due to firm sales in a

  10. Slide 10: 4) Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (compared with corresponding period of FY2023 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special Breakdown Segment FY2023 FY2024 Incr. FY2023 FY2024 Incr. Terms of Volume Costs 1-3

  11. Slide 11: 5-1) Life & Healthcare Solutions: Operating Income and Business Overview

    5-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY24.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume was up due to elimination of negative impact from

  12. Slide 12: 5-2) Mobility Solutions: Operating Income and Business Overview

    5-2) Mobility Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY24.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume was up, mainly in automotive applications [+]Sales Volume ・

  13. Slide 13: 5-3) ICT Solutions: Operating Income and Business Overview

    5-3) ICT Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY24.1-3Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger [+]Sales volume ・Overall sales volume was up due to recovery in semiconductor

  14. Slide 14: 5-4) Basic & Green Materials: Operating Income and Business Overview

    5-4) Basic & Green Materials: Operating Income before Special Items and Business Overview Comments Business Overview of FY24.1-3Q: [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Improvement in terms of trade driven by sales price revision ・Elim

  15. Slide 15: 6) Non-recurring Items

    6) Non-recurring Items (Billions of Yen) () Denotes a minus FY2023 FY2024 Incr. Items 1-3Q 1-3Q (Decr.) Loss (gain) on sales and disposal of non-current (1.3) (2.5) (1.2) assets Impairment loss (14.2) (6.5) 7.7 Others 3.1 0.1 (3.0) Non-recurring items total (12.4) (8.9) 3.5 1. Results for 3 rd Quart

  16. Slide 16: 7) Consolidated Statement of Financial Position

    7) Consolidated Statement of Financial Position (Billions of Yen) () Denotes a minus End of End of Incr. End of End of Incr. Items Items Mar.2024 Dec.2024 (Decr.) Mar.2024 Dec.2024 (Decr.) Current assets 1,150.6 1,078.9 (71.7) Liabilities 1,231.0 1,175.1 (55.9) Cash and cash 210.3 186.2 (24.1) Opera

  17. Slide 17: 8) Consolidated Statement of Cash Flow

    8) Consolidated Statement of Cash Flow (Billions of Yen) () Denotes a minus FY2023 FY2024 Incr. Items 1-3Q 1-3Q (Decr.) Ⅰ．Cash flows from operating activities (a) 115.0 141.4 26.4 ( of which Working capital ) 0.7 7.8 7.1 Ⅱ．Cash flows from investing activities (b) (69.8) (80.8) (11.0) Free cash flows

  18. Slide 18: 2. Outlook for FY2024

    2. Outlook for FY2024 (April 1, 2024 – March 31, 2025) ・In accordance with the organizational reform implemented on April 1, 2024, we have revised the segments to which Honshu Chemical Industry Co., Ltd. and certain other consolidated subsidiaries and equity method affiliates in ICT Solutions and Ba

  19. Slide 19: 1-1) Highlights of Consolidated Financial Outlook

    1-1) Highlights of Consolidated Financial Outlook (Billions of Yen) () Denotes a minus FY2023 FY2024 Incr.(Decr.) Items Full Year 1st Half Full Year 1st Half Full Year ％ Outlook Sales revenue 823.7 1,749.7 890.4 1,825.0 75.3 4% Operating income before special items 42.0 96.2 52.8 105.0 8.8 9% Non-re

  20. Slide 20: 1-2) Highlights of Consolidated Financial Outlook (Operating Income before Special Items)

    1-2) Highlights of Consolidated Financial Outlook (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials expected to increase, due to elimination of negative impact from inventory level adjustments in some markets in FY23. ［+］ ・Agrochemicals expected to i

  21. Slide 21: 2) Sales Revenue and Operating Income of Outlook by Business Segment

    2) Sales Revenue and Operating Income before Special Items of Outlook by Business Segment (compared with FY2023 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2024 FY2024 Terms of FY2023 Incr.(Decr.) FY2023 Incr.(Decr.) Volume Co

  22. Slide 22: 3-1) Life & Healthcare Solutions: Outlook and Business Overview

    3-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY24 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume expected to increase due to elimination of n

  23. Slide 23: 3-2) Mobility Solutions: Outlook and Business Overview

    3-2) Mobility Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY24 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume increase mainly in automotive applications [+]Sales v

  24. Slide 24: 3-3) ICT Solutions: Outlook and Business Overview

    3-3) ICT Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY24 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Overall sales volume expected to increase due to demand recovery in [+]

  25. Slide 25: 3-4) Basic & Green Materials: Outlook and Business Overview

    3-4) Basic & Green Materials: Operating Income before Special Items and Business Overview Comments Business Overview of FY24 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Improvement in terms of trade driven by sales price revision

  26. Slide 26: 4) Operating Income by Business Segment (4Q vs. 3Q of FY2024 Outlook)

    4) Operating Income before Special Items by Business Segment (4Q vs. 3Q of FY2024 Outlook) (Billions of Yen) FY2023 FY2024 4Q 2H Incr. Segment 3Q 3Q⇒4Q 2H Outlook Outlook (Decr.) (a) (b-a) (b) (a+b) Life & Healthcare Agrochemicals: Seasonality, changes in shipment 18.8 5.2 15.1 20.3 9.9 Solutions sc

  27. Slide 27: 5) Consolidated Statement of Cash Flow

    5) Consolidated Statement of Cash Flow (Billions of Yen) () Denotes a minus FY2024 Items FY2023 Incr.(Decr.) Outlook Ⅰ．Cash flows from operating activities (a) 161.3 190.0 28.7 Ⅱ．Cash flows from investing activities (b) (123.9) (175.0) (51.1) Free cash flows (a)+(b) 37.4 15.0 (22.4) Ⅲ．Cash flows fro

  28. Slide 28: 3. Appendix

    3. Appendix 1) Trends in Product Prices 2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment 3) Sales Revenue and Operating Income before Special Items by Business Segment 4) Outline of Business Segments 5) Data Highlights Copyright © 2025 Mitsui Chemicals, Inc.

  29. Slide 29: 1) Trends in Product Prices

    1) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan) : Change in Prices and Raw Materials Prices in Japan / BPA(China), PTA, TDI : Chinese Market Price) (ACP) : Asian contract price Year 2022 2023 2024 Month Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec.

  30. Slide 30: 2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment

    ２)Sales Revenue Increase/Decrease（Year on Year）by Business Segment (Billions of Yen) () Denotes a minus Sales revenue Breakdown Segment Comments FY2023 FY2024 Incr.(Decr.) Volume Prices 1-3Q 1-3Q Life & Healthcare Volume）Sales of vision care and agrochemicals were firm. 188.6 206.5 17.9 13.0 4.9 Sol

  31. Slide 31: 3) Sales Revenue and Operating Income before Special Items by Business Segment

    3) Sales Revenue and Operating Income before Special Items by Business Segment (Billions of Yen) () Denotes a minus Sales revenue FY2023* FY2024 Segment Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Outlook Life & Healthcare Solutions 57.1 62.0 69.5 83.1 67.5 70.6 68.4 91.5 Mobilit

  32. Slide 32: 4) Outline of Business Segments

    4) Outline of Business Segments Segment Businesses Main Products Vision Care Materials, Ophthalmic lens materials (MR™, Do Green™), Personal Care Materials, Medical materials (taurine), Life & Healthcare Nonwovens, Oral Care, Nonwovens (hygiene materials, industrial materials), Solutions Agrochemica

  33. Slide 33: 5-1) Data Highlights

    5-1) Data Highlights ～FY19：J-GAAP / FY20～：IFRS () Denotes a minus （Billions of Yen） Total Assets （Billions of Yen） 2,500 Net Sales/Sales Revenue 2,400 2,215.8 2,200 2,068.2 1,879.5 1,935.0 2,000 1,749.7 1,825.0 2,000 1,612.7 1,482.9 1,328.5 1,339.0 1,800 1,500 *1 1,211.7 1,558.1 1,600 1,501.1 1,480.

  34. Slide 34: 5-2) Data Highlights

    5-2) Data Highlights ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） 250.0 Capital Expenditure （Billions of Yen） Depreciation & Amortization 207.1 185.7 150.0 200.0 168.0 155.0 *3 102.0 150.0 *2 92.1 95.2 *1 100.0 76.6 84.2 81.2 93.2 100.0 76.3 61.9 45.7 49.5 52.1 50.0 50.0 0.0 0.0 '17 '18 '19 '20 '21 '

  35. Slide 35: Chemistry for Sustainable World

    Chemistry for Sustainable World Challenge Diversity One Team Copyright © 2025 Mitsui Chemicals, Inc.

Mitsui Chemicals — Q3 FY2024 Earnings Presentation on 6ix